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The Crystal Structure of a TL/CD8 Complex
at 2.1 A˚ Resolution: Implications for
Modulation of T Cell Activation and Memory
mice, MHCIb molecules comprise Qa-1, Qa-2, TL, T10,
T22, HFE, ZAG, and M3, ligands for the NKG2D receptor,
CD1, and FcRn.
MHCIb molecules serve more diverse and specialized
functions than MHCIa molecules. For example, CD1
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molecules present lipid antigens and M3 is a mouse1Laboratory of Immunobiology
MHCIb molecule with extraordinary preference for bind-Dana-Farber Cancer Institute
ing N-formylated peptides naturally processed by pro-2 Department of Medicine
karyotes and mitochondria (Wang et al., 1995). The Qa-13 Department of Pediatrics
molecule, and its human HLA-E homolog, presents pep-4 Department of Biological Chemistry
tides from the hydrophobic leader sequence of classicaland Molecular Pharmacology
MHCIa molecules to receptors on NK cells, rather thanHarvard Medical School
to TCRs, thereby permitting NK cells to monitor theBoston, Massachusetts 02115
MHCI expression status of target cells (Aldrich et al.,5 Division of Developmental Immunology
1994; Braud et al., 1997). The T10 and T22 moleculesLa Jolla Institute of Allergy and Immunology
serve as activation markers that are recognized by San Diego, California 92121
T cells following immune perturbation, although they are6 Biosciences Division
not capable of presenting antigens (Crowley et al., 1997;Argonne National Laboratory
Schild et al., 1994; Weintraub et al., 1994; Wingren etArgonne, Illinois 60439
al., 2000). The structurally defined T22b molecule has
severely modified 1 and 2 domains, as it is missing
the H1 segment of the 2 helix and lacks a classicalSummary
antigen-binding groove (Wingren et al., 2000). The FcRn,
which binds to Ig constant (C) regions, illustrates yetTL is a nonclassical MHC class I molecule that modu-
another possible mode of class I-mediated immune rec-lates T cell activation through relatively high-affinity
ognition. In this case, not only is the antigen-bindinginteraction with CD8. To investigate how the TL/
groove narrowed and compromised, but recognition ofCD8 interaction influences TCR signaling, we char-
Ig C regions is via the side rather than the top of the 1acterized the structure of the TL/CD8 complex us-
and 2 domains of FcRn (Burmeister et al., 1994).ing X-ray crystallography. Unlike antigen-presenting
The TL molecule, originally identified as a thymic leu-molecules, the TL antigen-binding groove is occluded
kemia tumor antigen, is encoded by T3b, T3d, T18d, andby specific conformational changes. This feature elim-
other closely related genes in the T cluster of the murineinates antigen presentation, severely hampers direct
MHC locus (Cheroutre et al., 1995; Old et al., 1963).TCR recognition, and prevents TL from participating
Although it was one of the first MHCIb molecules toin the TCR activation complex. At the same time, the
be defined, its function has long been enigmatic. TheTL/CD8 interaction is strengthened through subtle
constitutive expression of TL on epithelial cells of thestructure changes in the TL 3 domain. Thus, TL func-
small intestine in all mouse strains has suggested the
tions to sequester and redirect CD8 away from the
possibility that TL plays an important role in mucosal
TCR, modifying lck-dependent signaling.
immunity. Consistent with this notion, TL binds to
CD8 homodimers that are expressed constitutively
Introduction by many intestinal intraepithelial lymphocytes (iIEL),
whereas the predominant form of CD8, the CD8 het-
Classical, major histocompatibility complex (MHC) en- erodimer, is expressed on conventional MHC class I
coded class I molecules or MHC class Ia molecules restricted T cells. Moreover, the interaction of CD8
(MHCIa hereafter) are broadly expressed at high levels expressed by IEL with TL expressed by the antigen-
on the surface of many cell types, and they possess presenting cells alters TCR-mediated signals leading to
substantial allelic polymorphism. By contrast, the non- increased cytokine production without enhancing T cell
classical or MHC class Ib (MHCIb hereafter) molecules proliferation or cytotoxicity (Leishman et al., 2001).
are displayed at lower density. They manifest a much TL directly binds to the CD8 homodimer with a
more restricted tissue distribution and show little ge- significantly stronger affinity than to the CD8 hetero-
netic variation (Braud et al., 1999; Shawar et al., 1994; dimer (Kd 10 M versus 100 M), an affinity that sur-
Stroynowski and Lindahl, 1994). In humans, the MHCIb passes that of MHCIa molecules to either the CD8 or
molecules include HLA-E, -F, and -G, HFE, the MIC and CD8 (Leishman et al., 2001; Moody et al., 2001). This
ULBP proteins that bind to the NKG2D NK receptor, TL/CD8 interaction, however, occurs independently
CD1 proteins and the FcRn (neonatal Fc receptor), as of TCR and coreceptor-mediated antigen recognition.
well as several other proteins of unknown function. In As the TL3 domain conserves the primary CD8 docking
sequences found in H-2Kb, it was expected that TL
would interact with CD8. However, the basis for an aug-*Correspondence: jwang@red.dfci.harvard.edu
mented TL/CD8 affinity is uncertain. Moreover,7 Present address: Department of Pathology, Washington University
School of Medicine, St. Louis, Missouri 63110. whether peptide or lipid antigens can bind to TL and are
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Figure 1. Overall View of the TL/CD8Com-
plex Structure in Ribbon Drawing Prepared
with MOLSCRIPT (Krulis, 1991)
Different chains are labeled in their respective
colors. Glycans on CD8 are shown in ball-
and-stick drawing.
required for TL function is not known. Existing evidence plex in a view oriented as if TL (T18d) stands on the cell
membrane at the bottom and the CD8 homodimersuggests that TL does not bind antigen, as shown by
both the capability to refold TL protein produced by reaches TL(T18d) from an opposing T cell above. Al-
though the nonclassical MHCI molecule TL(T18d) is pre-recombinant methods in bacteria in the absence of pep-
tide (Weber et al., 2002) and the expression of TL in dicted to manifest different structure in conventional
antigen-binding regions from that of H-2Kb (LeishmanTAP-deficient cell lines (Holcombe et al., 1995; Rodgers
et al., 1995). On the other hand, between TL and MHCIa et al., 2001), we were able to utilize the entire H-2Kb/
CD8 complex for molecular replacement search, ob-molecules the conservation of certain residues, which
form hydrogen bonds to the N and C termini of bound taining a surprisingly straightforward result. As de-
scribed later, this is a consequence of the fact that withinpeptides (Bouvier and Wiley, 1994; Matsumura et al.,
1992), implicated a possible binding function in the the TL(T18d)/CD8 and H-2Kb/CD8 complexes, their
respective CD8 homodimers and MHC 3 and 2M“groove.” Consistent with this conservation, there are
some biochemical data indicative of TL binding to pep- domains, the major CD8 binding regions, can be super-
imposed to an RMS deviation of 0.99 A˚ for 390 C atoms.tides (Sharma et al., 1996).
To resolve these questions and define the structural This result emphasizes the topological similarity of the
CD8 binding modes of the two MHC molecules andbasis by which TL/CD8 ligation triggers modification
of the TCR-mediated activation signals, we have deter- suggests that the high affinity of TL(T18d)/CD8binding
must be a consequence of the fine tuning of detailedmined the structure of the TL/CD8 complex to 2.1 A˚
resolution. This represents the first structure of CD8 in intermolecular interactions rather than of a distinctly
different binding mode, consistent with results of recentcomplex with any MHCIb molecule. More importantly,
our data here, in conjunction with our earlier H-2Kb/ mutation data (Devine et al., 2002). The surface buried
area for the TL(T18d)/CD8 complex is 3704 A˚2 (1890 A˚2CD8 complex structure (Kern et al., 1998), show how
the antigen-presenting activity of this MHCIa-related for TL and 1814 A˚2 for CD8), as opposed to 3514 A˚2 for
H-2Kb/CD8 complex (1766 A˚2 for H-2Kb and 1748 A˚2molecule has been structurally eliminated with concur-
rent augmentation of CD8 binding. This information of- for CD8) using the program AREAIMOL in CCP4 suite
(CCP4, 1994) with a 1.7 A˚ as radius probe.fers a view as to how CD8 functions not as a corecep-
tor during T cell activation but rather as a modulator of Strikingly, the antigen-binding groove defined by the
cleft between the two helical regions of the 1 and 2the CD8 coreceptor/TCR signaling complex for-
mation. domains in a classical MHCIa is obliterated in TL(T18d).
Figure 2A is the surface representation comparison of
TL(T18d) versus H-2Kb viewed toward the platform. InResults and Discussion
the case of H-2Kb, the MHCI-bound VSV8 octapeptide
has been removed in order to reveal the antigen-bindingOverview of the TL(T18d)/CD8 Complex
The structure of the murine TL(T18d)/CD8 complex groove. The contrast is readily apparent: TL(T18d), unlike
H-2Kb, has no space to accommodate a peptidic or lipidwas determined to 2.1 A˚ using the molecular replace-
ment method with the H-2Kb/CD8 structure (PDB antigen. This finding confirms the biological observation
that, as a specialized nonclassical MHCIb molecule,code 1bqh) as a search model. Figure 1 shows the com-
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Figure 2. TL-Specific Amino Acid Residues
that Seal the “Antigen Binding Groove” in TL
(A) The surface representation of TL (on the
right) versus H-2Kb (on the left) is viewed to-
ward the platform with the “groove” in the
vertical orientation and was prepared with
GRASP (Nicholls et al., 1991). In order to high-
light the structural distinction of TL versus
H-2Kb platforms, the peptide bound to H-2Kb
has been removed. The deep and wide
groove in the classical MHCIa molecule H-2Kb
strikingly contrasts with the essentially
closed groove in the nonclassical MHCIb
molecule TL. In the TL/CD8 structure, a
few discrete water molecules are found near
where the N terminus of the bound peptide
lies in a classical MHC class I structure. These
waters are not shown here, leaving a small
depression as seen in the upper part of the
TL surface.
(B) A top view of the 1  2 platform (90
rotation from Figure 2A) showing a cluster of
hydrophobic residues that may play a major
role in providing energy to pull the two helical
regions toward one another within direct con-
tact. TL-specific residues are colored in dark
blue, whereas conserved residues are in red.
In this overlay, the C trace of TL is in blue
and that of H-2Kb with bound peptide is in
gold. Shown in the figure also is the footprint
(in magenta) of the 2C TCR CDR1 and CDR2
loops from both V and V domains derived
from 2C TCR/H-2Kb structure (Garcia et al.,
1996).
(C) A side view of the 12 platform show-
ing the hydrogen bond network in the TL
groove. For clarity, 1 is colored in magenta,
2 in green, the floor  sheet in yellow, and
selected side chains in red ball-and-stick.
The most prominent feature in the network is
centered at the TL-specific Glu114 on the 5
strand, which forms hydrogen bonds to TL-
specific residues. Also shown here are the
three bound water molecules near where the
peptide’s termini would have been. (B) and
(C) were prepared with MOLSCRIPT (Krulis,
1991).
TL(T18d) is incapable of presenting antigen for TCR rec- Within the 274 residue  chain there are 82 substitu-
tions in TL(T18d) relative to H-2Kb. Sixty-nine differencesognition (Weber et al., 2002). There is no electron density
between the two helical regions aside from several dis- are found in the 180 residue 1  2 domain platform
(62% identity) while only 13 reside in the 3 domaincrete densities assignable to water molecules posi-
tioned primarily where the N terminus of the antigenic (86% identity). Importantly, there are no deletions or
insertions of residues throughout (Teitell et al., 1994).peptide would reside in a classical peptide MHCI
(pMHCI) structure. Similar substitutions are evident in the other TL mole-
cules, T3b, T3d, and T3a, with a single 3 residue deletion
in the latter (Figure 3). As we shall discuss, these substi-The Structure of the TL(T18d) Molecule
The overall structure of TL(T18d) resembles a classical tutions account for both the inability of TL to present
antigen and its conversion into a stronger CD8 bind-MHCI molecule. The heavy chain contains 1 and 2
domains that form a platform composed of a structurally ing protein compared to the classical MHCIa molecule
H-2Kb. The high sequence identity among TL moleculesconserved eight-stranded  sheet on the bottom topped
by two  helical regions and an Ig-like 3 domain below (92%, see Figure 3) indicates that the T18d structure
should be representative of all TL proteins. Hence, here-the sheet (Figure 1). The 2M light chain is a conserved
99 residue Ig-like domain paired with the 3 domain. after we shall refer to T18d as TL. In this section, the
large conformational changes in platform are described,As mentioned above, compared to the murine MHCI
molecule H-2Kb, TL(T18d) maintains the same configura- whereas the more subtle changes in 3 domain that
afford stronger CD8 binding will be discussed in thetion as its membrane proximal Ig-like domains, but has
a substantially different arrangement of the 1 and 2 next section.
The major structural changes in the platform resultingdomains.
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Figure 3. Sequence Alignment of TL Family Members and H-2Kb
Secondary structure elements are marked with broken lines. Those identical residues are colored in red, whereas conserved residues are in
black and variant ones in blue, respectively. The sequences were from Chen et al. (1985), Mashimo et al. (1992), and Pontarotti et al. (1986).
from this sequence variation can be divided into two membrane proximal Ig-like domains 3 and 2M. In fact,
a one-turn helical extension of the 2 region results incategories: alteration of secondary structure and modifi-
cation of side chain distribution. The 8 stranded  sheet about a 2.5 A˚ movement of the entire platform toward
the 3 domain (Figure 4A), which allows for a TL-specificthat is conserved in all MHC molecules remains un-
changed. However, the conformation of the loop linking contact between the 2-3 loop of the 1 domain and
BC loop of the 3 domain. This in turn yields slight strands 3 and 4 in TL has significantly changed
because of sequence differences. The Gly40-Gly43 in movement of the 2M toward the 3 domain, too, due
to the extensive interactions between the 2M domainTL forms a  turn, curving up and in doing so, likely
pushing the 1 helix toward the 2 helix (Figure 2B). and the bottom of the platform.
Another unique feature of the TL’s 2 helical regionThe 1 helical region, like in H-2Kb, consists of a short
310 helix of Arg50-Glu55 and a long  helix of Gly56- is at the Pro163, one residue after the Gly162 bending
point (Figure 2B). As the carbonyl group of Tyr159 can-Asn86. Interestingly for TL, the mid-portion of the long
helix of 1 overwinds, thereby becoming a 310 helix, from not form a hydrogen bond to Pro163 in an  helical
conformation, it turns to the amide group of Cys164Phe74 to Thr80. This energetically unfavorable long 310
helix is stabilized by the hydrogen bond between Trp147 instead, and so follows the Leu160-Lys165 pair. Appar-
ently the short 	 helix conformation unwinds the helicalon the 2 helix and the TL-specific Asn77 on the 1 helix
(Figure 2C) and the aromatic ring clustering of Phe74 and region, making the Gly162 bend sharper than that in
H-2Kb and in a bending direction opposite to that of 1.TL-specific Phe73 on 1 as well as Trp147 and the TL-
specific Tyr152 on 2 (Figure 2B), which help to close Since the disulfide bond of Cys164-Cys101 fixes the
C-terminal portion of 2 on the  sheet platform, theup the peptide binding groove. The 2 helical region in
H-2Kb has a short  helix of Asp137-Gln149 and a long overall consequence of the bend is to move the N-ter-
minal portion of 2 toward the 1, further narrowing the helix of Gly151-Gly175 with a bend at the Gly162 (Fig-
ure 2B). In all MHCIa and MHCIb structures surveyed, groove. Compared to the H-2Kb structure, the largest
C atom movements are 4.3 A˚ for Arg75 of 1 andthis long helix kinks 90 at its C-terminal Gly175 and is
followed by another short helix of Gly175-Arg181. By 2.6 A˚ for Tyr152 of 2, respectively. The net result is to
approximate the 1 and 2 helical regions about 7 A˚contrast, in TL a Gly175Arg substitution allows the long
helix to extend one additional turn to Thr178 and then closer to each other than in the corresponding region
of a class Ia molecule where the P6-P7 residues of andirectly link to the 3 domain starting at Asp183 (Figure
2B). This 2 helix elongation has a net effect of changing antigenic peptide would reside.
Beyond the closer apposition of 1 and 2 helices inthe relative disposition between the platform and the
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Figure 4. Structural Comparison of TL/
CD8 and H-2Kb/CD8 Complexes
(A) Superposition of complexes based on
their MHCI 3 domains. In the figure prepared
with MOLSCRIPT (Krulis, 1991), the TL struc-
ture is represented by thick colored lines with
domains labeled in respective colors, while
H-2Kb is represented by thin black lines. The
two insets correspond to their respective
boxed regions, highlighting detailed intermo-
lecular interactions. The orientation differs
from that in (A) to emphasize the detailed con-
tacts. (Inset blue) Detailed intermolecular in-
teractions between the AB and EF loops of
TL and the DE loop of CD82. The color codes
remain the same as in the superposition fig-
ure. (Inset green) Detailed intermolecular in-
teractions between the BC and C’C” loops of
CD81 and the CFG face of TL.
(B) Comparison of MHC class I AB loop con-
formations. In HLA-A2 the AB loop points to-
ward the reader, away from CD82, whereas
in H-2Kb it flips inward and toward CD82. In
the case of TL, the tip of the AB loop leans
even further toward CD82.
TL, amino acid substitutions within the groove occupy are TL-specific substitutions (Figure 2C). This network
lies underneath the P6 pocket region and should havethe narrow intervening space. As shown in Figure 2B,
the TL-specific Val67 and Phe73 from the 1 helix, the a significant facilitative effect in approximating the1 helix
with the 2 helix, on which the Tyr152 and Arg156 lie.Tyr152 from the 2 helix, and the Tyr9 and Tyr99 from
the  sheet floor below, joined by conformationally read- An earlier study indicated that there are ten conserved
antigen-binding site residues among 22 human MHCIjusted residues, conserved Tyr7, Phe74, and Tyr159, fill
up the groove. Hydrophobic interactions among these sequences and 13 murine MHCIa sequences (Bjorkman
et al., 1987). Three of those residues (Tyr7, Tyr59, andresidues might provide the major energy to pull the two
helical regions toward one another within direct contact. Tyr171) form a network of hydrogen bonds directly to
the N terminus of the bound peptide and another threeIt is interesting to note from the superposition of TL and
VSV8/H-2Kb shown in the Figure 2B that these hydropho- (Tyr84, Thr143, and Lys146) to the peptide’s carboxyl
group. In other words, most of these conserved residuesbic residues evenly span the peptide binding footprint.
Additionally, there are some hydrogen bond changes define a sequence-independent peptide binding mode,
a characteristic structural feature of class I MHC antigenpromoting this conformational transformation. The most
prominent one is centered at the TL-specific Glu114 on presentation (Madden, 1995). Interestingly, these ten
residues remain conserved in the seven known TL se-the 5 strand. Glu114 forms three hydrogen bonds to
His116, Tyr152, and Arg156, respectively, all of which quences (Obata et al., 1994). Our TL structure shows
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that bound water molecules are found in close proximity than the distance between the H-2Kb 3 domain and
CD8. This result indicates the overall proximity of TLto where the peptide’s N terminus would residue in an
versus H-2Kb in CD8 binding, which will be discussedMHCIa structure. As shown in Figure 2C, a hydrogen
in detail below.bond network from one water molecule (labeled “O25”
The major CD8 binding region resides on the CDin the figure) to Tyr7, Tyr171, and Glu63 is formed. The
loop of the 3 domain for both human and mouse MHCbound waters in TL help maintain the conformation of
molecules, encompassing residues 219-228 (Gao et al.,these buried conserved tyrosines for structure integrity.
1997; Kern et al., 1998). Within this segment, the onlyThe peptide’s carboxyl terminus is relatively close to
TL versus H-2Kb substitution observed for most TL mole-the molecular surface with its side chain deeply buried.
cules is the Met228Thr (Figure 3). The side chain ofIn TL there is also another water molecule (labeled “O7”)
Thr228 is not directly engaged in CD8 binding. Instead,in association with the C-terminal anchoring pocket.
its hydroxyl group hydrogen bonds to the carbonyl oxy-This water forms a similar hydrogen bond network to
gen of Leu224. This increases the number of hydrogenconserved Thr143 and TL-specific Asn77 and Thr80.
bonds within the CD loop (Kern et al., 1998), making theThe side chains of the conserved Tyr84 and Lys146 are
loop of TL more rigid. It can be envisioned that a rigidifiedturned such that they become solvent exposed.
CD loop favors CD8 binding from an entropic point ofAnother interesting observation from the Figure 3 se-
view.quence alignment of known TL molecules is that while
Most of the intermolecular contacts detailed pre-those residues that show mouse strain-specific se-
viously between CD8 and H-2Kb (Kern et al., 1998)quence differences are essentially exposed, none are
are conserved in the TL/CD8 complex. An exceptionlocated on the top surface of TL. Hence, this allelic TL
is the loss of one hydrogen bond between the H-2Kb 3variation cannot be directly recognized by the TCR in a
domain’s Lys198-NZ and the carbonyl group of CD81conventional manner. That TL-specific displacement of
Ser59, due to the Lys198Asp substitution in TL. How-the 1 helix likely eliminates the TCR V CDR2 contact
ever, TL gains one hydrogen bond between the Arg194(Figure 2B) observed with the 2C TCR/H-2Kb interaction
NH1 and the carbonyl group of Asn61 in the nearby(Garcia et al., 1999) supports this notion. Alteration of
region (Figure 4A, inset blue). Arg194, a residue con-residues on the platforms of TL versus H-2Kb where
served in TL and H-2Kb, readjusts its side chain to formputative TCR contacts would be made is also striking.
this additional hydrogen bond, afforded by the closerThose most important for TCR binding include (H-2Kb to
proximity of the TL/CD8 interaction. Elsewhere, in TL/TL) Glu61Ala, Gln65Asp, Lys66Ile, Arg79Asn, Lys89Asn,
CD8 relative to H-2Kb/CD8, more intermolecularLeu141Asp, His145Ser, Arg155Leu, Trp167Ser, and
contacts are observed, in particular near the bottom ofLys173Asp. The tendency is to have less featured sur-
the complex (Figure 4A, inset blue) between the DE loopface, which will also significantly alter the immune recog-
of the CD82 subunit and the TL molecule’s AB and EFnition interface of TL.
loops. In comparing the murine H-2Kb/CD8 complex
to the human HLA-A2/CD8 complex, we noticed ear-Structural Features of TL Enhancing CD8 Binding
lier that the AB loop of the murine H-2Kb 3 domain has
Collectively, the above findings indicate that substantial
a different conformation from the corresponding loop
structural adaptations have occurred in the 1 and 2
in human HLA-A2 (Kern et al., 1998), bending toward
domains of the TL molecules, eliminating antigen-pre-
CD82 and contributing more binding energy. In HLA-
senting function. On the other hand, the 3 domain is A2, the A and B strands form a 10 residue-long antiparal-
more conserved between TL and H-2Kb (Obata et al., lel  structure up to and including the His192-Thr200
1994) (Figure 3), suggesting that CD8 binding would be pair, followed by a  bulge at Ala193 and Val194 (Figure
preserved. In fact, binding experiments with recombi- 4B, left panel). The AB loop is a normal  turn of Ser195-
nant TL expressed in a baculovirus system demonstrate Glu198, pointing away from CD8 with no contacts. In
that the TL/CD8 affinity is significantly stronger than H-2Kb, probably due to the Ser195Pro substitution, the
that of H-2Kb/CD8, consistent with the ability of TL A-B strand pairing extends two more residues to
tetramers to specifically detect CD8 homodimers in Arg194-Lys198, leaving Pro195-Glu196-Asp197 as an
flow cytometry experiments (Leishman et al., 2001). irregular loop and bending toward the CD82 subunit
Functional conservation of the CD8 binding site in the for contacts (Figure 4B, middle panel). The TL 3 domain
TL 3 domain has been demonstrated by molecular chi- has a similar AB loop conformation as in that of H-2Kb but
meric analysis; CD8 can serve as a coreceptor for CTL with a slightly different internal hydrogen bond pattern
recognition of a chimeric MHCIa molecule containing (Figure 4B, right panel). The Glu197Gly substitution in TL
the TL 3 domain (Teitell et al., 1991). Nonetheless, dif- permits residue 197 to assume the otherwise disallowed
ferences in murine CD8 affinity for MHCIa H-2Kb and dihedral conformation of 
  156 and φ  96. Its car-
H-2Db are linked to small conformational changes in bonyl group no longer forms a hydrogen bond to the
their respective 3 domains (Moody et al., 2001). neighboring D strand like that in H-2Kb, but instead turns
We are now in the position to directly compare the to hydrogen bond to the side chain of Arg194 within the
structures of the murine TL/CD8 complex to the mu- AB loop. This brings the AB loop even closer to the
rine H-2Kb/CD8 complex (Kern et al., 1998), exploring CD82 subunit. Since the E strand pairs with the B
the basis of affinity variation. We have noticed that the strand all the way up to residue Ser251 at the beginning
CD8 homodimer somewhat more closely approxi- of the DE loop, it also brings the DE loop closer to CD8.
mates the 3 domain in the TL/CD8 complex than in The overall consequence of the closer abutment in this
the H-2Kb/CD8 complex. The distance between mass region is that there are six pairs of hydrophobic contacts
and one hydrogen bond between the TL molecule’s ABcenters of the TL 3 domain and CD8 is 0.35 A˚ shorter
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and EF loops and the CD82 DE loop, whereas there coprotein (ZAG) (Sanchez et al., 1999), murine T22 (Win-
gren et al., 2000), and murine Qa-2 (He et al., 2001).are only two hydrophobic contacts and two hydrogen
bonds between the corresponding regions of H-2Kb/ Their diversity is striking: the widely opened classical
MHCIa antigenic peptide binding groove of H-2Kb, theCD8 complex. The comparison is manifest from Fig-
ure 4A, inset blue. specialized peptide binding groove of Qa-2 and H2-M3,
the slightly narrowed but much deepened antigenic lipidIn an analogous fashion, the interaction between TL
and CD81 is also further “reinforced” (Figure 4A, inset binding groove in CD1 molecules, the very narrowed
groove in HFE, and closed grooves in TL and FcRn.green). For instance, Gln34 of the CD81 subunit BC
loop makes two hydrogen bonds (both longer than 3.2 A˚) There are additional examples of structural diversity
among the molecules. For example, T22 displays a trun-to the Leu215-NH and Thr216 side chain, respectively,
on the C strand of H-2Kb 3 domain, whereas the same cated 2 helix at its N-terminal half (Wingren et al., 2000),
while ZAG and MIC-A do not associate with a 2M lightGln34 of the CD81 subunit appears to make two hydro-
gen bonds to the Leu215 backbone groups with notice- chain (Li et al., 1999; Sanchez et al., 1999). The degree
of structural deviation of these molecules from classicalably shorter distance (both shorter than 2.8 A˚) on TL.
There are also more hydrophobic contacts in the TL/ MHCIa molecules matches with their evolutionary phy-
logeny. Using an 3 domain sequence alignment to con-CD81 interaction as clearly shown in Figure 4A, inset
green. Another unique interaction in murine H-2Kb/ struct a phylogenetic tree, the nonclassical MHCIb mol-
ecules with the exception of FcRn are closer to MHCIa,CD8 complex is between the N terminus of CD81
and H-2Kb (Kern et al., 1998). By comparison, the N whereas the FcRn and CD1 family are closer to MHC
class II (MHCII) molecules (Kulski et al., 2001). The major-terminus of TL curves away from 2M and toward the
3 domain, creating a different set of interactions with ity of these MHCI-like molecules still play roles in im-
mune responsiveness. A few perform unrelated func-CD81, while the number of interactions does not
change. For example, the carbonyl group of CD81 Lys1 tions, however, such as HFE, which binds to the
transferrin receptor and regulates iron homeostasismakes a hydrogen bond to the side chain of the 2M
domain in H-2Kb. In TL, this same Lys1 residue uses its (Feder et al., 1998).
Class Ia and class II MHC molecules are known toside chain to hydrogen bond to Glu229 of the TL 2
domain; also Arg8 of CD8 1 forms a hydrogen bond bind CD8 and CD4 coreceptors selectively, with CD8
mainly contacting the MHCIa 3 domain CD loop (Gaowith the carbonyl group of Lys58 of 2M in H-2Kb, but
a salt bridge to Asp122 of the TL 2 domain. This is et al., 1997; Kern et al., 1998) and CD4 “inserting” into
the junction between two membrane proximal Ig-likeactually an intricate area, where CD81 meets both
heavy and light chains of MHCI molecule. A Leu29Ala domains (Wang et al., 2001). Several of the aforemen-
tioned class Ib molecules also interact exclusively withmutation in CD8, for instance, substantially reduces
H-2Kb binding, but has no effect for TL binding (Devine CD8 but others, such as HFE, do not interact with CD8
at all. While TL has a stronger affinity for CD8 thanet al., 2002). For CD81, this Leu29 points to the tip of
DE loop of 2M, in a quite crowded environment. In the its classical MHCIa H-2Kb counterpart, another MHCIb
molecule, murine Qa-2, has a much weaker affinity (Tei-H-2Kb complex, the Lys58 from the 2M DE loop forms
a salt bridge to Glu27 of CD81, and the nearby Leu29 tell et al., 1993), also associated with the characteristic
AB loop conformation of its 3 domain (He et al., 2001).apparently participates to stabilize the interaction,
which may explain why the CD8 Leu29Ala mutation is T22 is a  T cell receptor ligand that apparently does
not present antigens (Crowley et al., 1997). At least oneimpairing. On the other hand, in the TL complex the side
chain of Lys58 swings away from CD81 Glu27, so the of the proposed TCR  binding sites (Pro124) on T22
may prevent any coreceptor engagement since it liessame mutation of Leu29Ala may not have such an effect.
Given the similar general features of the two MHCI/ very close to the T22 3 domain (Wingren et al., 2000).
The ZAG-related MHCIb MIC-A molecule is unlikely toCD8 interfaces, the structural differences are quite
small. Nonetheless, the binding affinity difference in the associate with the CD8 coreceptor due to its unusual
3 domain and variant CD loop (Sanchez et al., 1999).receptor-ligand interaction results from exquisite con-
formational changes between the TL/CD8 versus Moreover, since both ZAG and MIC-A do not associate
with 2M, which contributes significantly to the CD8H-2Kb/CD8 pairs. From the sequence alignment
shown in Figure 3, it is obvious that all of the above- interaction surface, they most likely will not ligate CD8
efficiently, if at all.mentioned T18d residues associated with the stronger
CD8 binding are conserved among TL molecules. Pre-
dictably, those other TL molecules should manifest TL/CD8 Interaction as a Modulator of the
higher CD8 binding affinity than H-2Kb. TCR/CD8/pMHCIa Signaling Complex
Both the inability of TL to bind antigenic ligands and the
narrow interhelical TL geometry, unfavorable to TCRStructural Comparison of Nonclassical MHC
Molecules and Implications for Coreceptor Binding binding, imply that TL cannot participate in cognate TCR
recognition functions. Consistent with this notion is theThere have been multiple crystal structures of nonclassi-
cal MHCIb and MHCI-like molecules available, including observation that TL transgenic mice expressing T18d
under control of the H-2Dd promoter fail to foster CD8neonatal human Fc receptor (FcRn) (Burmeister et al.,
1994), murine H2-M3 (Wang et al., 1995), mouse CD1d T lineage development when crossed onto a Tap/
background (H.C. and M.K., unpublished data). At the(Zeng et al., 1997) and human CD1b (Gadola et al., 2002),
human hemochromatosis protein HFE (Lebron et al., same time, presentation of a stronger CD8 binding site
with preference for CD8 over CD8 favors ligation1998), human MIC-A (Li et al., 1999), human Zn-2-gly-
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Table 1. Crystallographic Data
Crystal 1a Crystal 2b
Space group P3121 P3121
Cell parameters
a  83.8 A˚ 77.0 A˚
b  83.8 A˚ 77.0 A˚
c  178.8 A˚ 176.0 A˚
  90.0 90.0
  90.0 90.0
  120.0 120.0
Reflections
Resolution limits 50.0–4.5 A˚ 50.0–2.1 A˚
Total number 18,581 171,093
Unique 4,634 35,619
I/sigma(I) 6.0 [1.9] 9.7 (3.1)
Completeness 98.9% [99.3%] 98.9% (100.0%)
R-merge 21.9% [68.2%] 7.1% (50.0%)
Refinement Statistics
Resolution range 20.0–4.5 A˚ 50.0–2.1A˚
R-work 44.4% 21.7%
R-free 43.3% 27.9%
Rms deviation bonds 0.011 A˚
Rms deviation angles 1.643
Ramachandran plot
Favored Allowed Generous Unfavored
Heavy chain 88.0% 10.4% 1.7% 0.0%
2M 88.4% 11.6% 0.0% 0.0%
CD8a1 81.5% 17.6% 0.9% 0.0%
CD8a2 89.2% 10.8% 0.0% 0.0%
[ ]Statistics in 4.664.50 A˚ shell; ( )Statistics in 2.182.1 A˚ shell.
aThe crystal was undehydrated and data were collected at room temperature using in-house X-ray source.
bThe crystal was dehydrated and data were collected at 160 using synchrotron X-ray source.
of CD8 with TL, rather than with MHCIa molecules. thus sequestering the CD8-associated lck away from
the TCR and possibly redirecting the kinase to otherAs a consequence, CD8 that can be coexpressed
together with a conventional coreceptor will preferen- immune receptors. It is conceivable that shifts in the
responsiveness of effector T cells, for example from IL-2tially interact with TL while the coreceptor CD4 or CD8
ligates with the MHC involved in the TCR activation to IL-15 dependency, or the upregulation of survival
factors such as Bcl-2 and Bcl-XL observed in memorycomplex. In this view, the TL/CD8 interaction disrupts
the potential coreceptor function of CD8, diverting CD8 T cells (Ku et al., 2000; Lodolce et al., 1998; Suzuki
et al., 1997), are predicated on this signaling componentCD8 from participation with the TCR in bidentate
binding to the same MHCIa molecule. Recently it was compartmentalization. In this way, TL/CD8-mediated
attenuation of TCR ligation may prevent activation-shown that such specific interaction of CD8 constitu-
tively expressed by the activated IEL with TL constitu- induced cell death while selectively stimulating survival
pathways for memory T cell precursors. Such TL/CD8tively expressed by intestinal epithelial cells significantly
modifies TCR activation signals (Leishman et al., 2001). interaction appears to promote the survival of constitu-
tively activated IEL (Leishman et al., 2001). This view isCD8 expression is not unique to IEL and its expres-
sion can be induced upon activation of conventional T consistent with the observations described in a recent
study by Konno et al. (2002) in which human CD8 Tcells as well. Similarly, TL can be induced upon dendritic
cells were identified that expressed a typical memorycell activation and it is thus feasible that the interaction
phenotype. The latter finding further indicates that theof activation-induced CD8 and TL molecules modifies
CD8-mediated process of memory formation is con-activation signals that might determine the fate of the
served across species.stimulated effector T cells. The CD8 chain harbors the
signaling component of the CD8 coreceptor molecule,
Experimental Proceduresby binding the active tyrosine kinase p56lck (Molina et
al., 1992; Straus and Weiss, 1992; Turner et al., 1990; Production and Purification of CD8 and TL
Yao et al., 1990). It is the CD8 chain, however, that The N-terminal extracellular fragment of murine CD8 chains (resi-
permits translocation of the CD8 coreceptor to lipid rafts dues 1–122), with leucine-zipper-forming acidic or basic segments
at carboxyl-terminal, respectively (resulting in a homodimer forma-bringing the CD8-associated lck in close proximity to
tion), was expressed in and purified from Lec3.2.8.1 cells by 2H11-the raft-associated TCR activation complexes (Arcaro
affinity chromatography. The leucine zipper was cleaved by throm-et al., 2001). This translocation event is required for
bin and the deglycosylation was performed by Endo-H treatment
efficient induction of downstream signaling cascades as described previously (Kern et al., 1998). The CD8 protein was
and T cell activation. When interacting with TL, CD8 further purified by gel-filtration on a Superdex 75 column and buffer
exchanged to 10 mM HEPES (pH 7.0) and 0.025% sodium azide.is largely excluded from these activation complexes,
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The cDNA of murine T18d heavy chain (encoding the residues 1–120 of the CD81 subunit, residues 4–125 of the CD82 subunit,
and 164 water molecules. No meaningful electron densities were1–274) was inserted into the expression vector pET-23b and ex-
pressed in E. coli BL21 (DE3). The inclusion bodies were purified found for the N-terminal three residues of the CD82 subunit, and
the C-terminal five residues of the CD81 subunit. The densities forand dissolved in guanidine-HCl solution (1.1g/ml of guanidine HCl
in 50 mM Tris-HCl [pH 8.0], 1 mM EDTA, and 10 mM 2-mercaptoetha- residues Ile17, Ser18, and Glu19 in the 12 loop of the TL molecule
were also poor; these surface exposed residues have neverthelessnol). The denatured heavy chain (TL) and human light chain (2m)
inclusion bodies were added each to 5 ml of 3 M guanidine-HCl, 10 been tentatively modeled.
To verify that the 2.1 A˚ structure does not have significant defor-mM sodium acetate, and 10 mM EDTA (pH 4.2). An efficient refolding
was achieved by rapidly diluting the inclusion bodies into 1 liter mation caused by the dehydration treatment, the refined structure
was back subjected to five rounds of rigid body refinement againstcold refolding buffer (100 mM Tris-HCl [pH 8.3], 400 mM L-arginine,
2 mM EDTA, 5 mM reduced glutathione, 0.5 mM oxidized glutathi- the 4.5 A˚ resolution data collected at room temperature without
such treatment. The RMSD value for all C atoms between the inputone, and 0.2 mM PMSF) with vigorous stirring. The final concentra-
tions of the heavy and light chains were 1 and 2 M, respectively. and output models was only 0.54 A˚. This result clearly indicates that
the dehydration treatment has little effect on domain arrangement.After the refolding solution was incubated at 10C with slow stirring
overnight, the second and third batches of inclusion bodies were Rather, the treatment induces much tighter molecular packing than
that before treatment. This is manifest in the unit cell dimensionadded in every 6–12 hr, and a further overnight incubation was
performed. The refolded material was then concentrated to 10 ml difference that gives the treated crystal about 17% reduction in
volume (Table 1).and sized on a Sephacryl S-300 Hi-Prep column (HR 26/60), followed
by ion exchange on a Mono-Q column using a NaCl gradient elution.
Subsequently, the purified TL protein was buffer exchanged to 10 Acknowledgments
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